BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Villar LM, Cruz HM, Barbosa JR, Bezerra CS, Portilho MM, Scalioni LP. Update on hepatitis B and C virus diagnosis. World J Virology 2015; 4(4): 323-342 [PMID: 26568915 DOI: 10.5501/wjv.v4.i4.323] [Cited by in CrossRef: 47] [Cited by in F6Publishing: 50] [Article Influence: 5.9] [Reference Citation Analysis]
Number Citing Articles
1 Garg R, Ramachandran K, Jayashree S, Agarwal R, Gupta E. Evaluation of blood samples collected by dried blood spots (DBS) method for hepatitis B virus DNA quantitation and its stability under real life conditions. Journal of Clinical Virology Plus 2022;2:100111. [DOI: 10.1016/j.jcvp.2022.100111] [Reference Citation Analysis]
2 Campu A, Muresan I, Craciun A, Cainap S, Astilean S, Focsan M. Cardiac Troponin Biosensor Designs: Current Developments and Remaining Challenges. IJMS 2022;23:7728. [DOI: 10.3390/ijms23147728] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Santana GM, Silva AKS, Foguel MV, Dutra RF. An ultrasensitive electrochemical immunosensor for hepatitis C antibodies based on one-step-eletrosynthetized polypyrrole–graphene nanocomposite. J Mater Sci. [DOI: 10.1007/s10853-022-06992-5] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Flores GL, Mota JC, da Silva Andrade LT, Lopes RS, Bastos FI, Villar LM, Komatsu H. Performance of HCV Antigen Testing for the Diagnosis and Monitoring of Antiviral Treatment: A Systematic Review and Meta-Analysis. BioMed Research International 2022;2022:1-17. [DOI: 10.1155/2022/7348755] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Huang X, Zheng X, Shen C. Antiviral Therapy with Entecavir following Antituberculosis Therapy Alleviates Liver Injury and Restores Innate Immunity in Tuberculosis Patients Coinfected with Hepatitis B Virus. Evid Based Complement Alternat Med 2021;2021:2884151. [PMID: 34764998 DOI: 10.1155/2021/2884151] [Reference Citation Analysis]
6 Chen X, Wang S, Tan Y, Huang J, Yang X, Li S. Nanoparticle-Based Lateral Flow Biosensors Integrated With Loop-Mediated Isothermal Amplification for the Rapid and Visual Diagnosis of Hepatitis B Virus in Clinical Application. Front Bioeng Biotechnol 2021;9:731415. [PMID: 34595159 DOI: 10.3389/fbioe.2021.731415] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 W Akazong E, Tume C, Ayong L, Njouom R, Kenmoe S, Njankouo R, Kuiate JR. Cross-sectional hospital-based study on the seroprevalence of hepatitis B virus markers among healthcare workers, NWR, Cameroon. BMJ Open 2021;11:e045716. [PMID: 34210724 DOI: 10.1136/bmjopen-2020-045716] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Bezerra CS, Portilho MM, Frota CC, Villar LM. Comparison of four extraction methods for the detection of hepatitis B virus DNA in dried blood spot samples. Microbiologyopen 2021;10:e1161. [PMID: 33970537 DOI: 10.1002/mbo3.1161] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Batskikh SN. Resolved Hepatitis B: Achieved or Imaginary Wellbeing? Rossijskij žurnal gastroènterologii, gepatologii, koloproktologii 2021;31:7-19. [DOI: 10.22416/1382-4376-2021-31-1-7-19] [Reference Citation Analysis]
10 Chen X, Zhou Q, Dong S, Wang S, Liu R, Wu X, Li S. Multiple Cross Displacement Amplification Linked with Nanoparticles-Based Lateral Flow Biosensor in Screening of Hepatitis B Virus in Clinical Application. Infect Drug Resist 2021;14:1219-29. [PMID: 33790592 DOI: 10.2147/IDR.S297645] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Narayanamurthy V, Jeroish ZE, Bhuvaneshwari KS, Samsuri F. Hepatitis C virus (HCV) diagnosis via microfluidics. Anal Methods 2021;13:740-63. [PMID: 33511975 DOI: 10.1039/d0ay02045a] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
12 Ndako JA, Nwankiti OO, Olorundare JO, Ojo SKS, Okolie CE, Olatinsu O, Dojumo VT. Studies on the serological markers for hepatitis B virus infection among type 2 diabetic patients. J Clin Lab Anal 2021;35:e23464. [PMID: 33410548 DOI: 10.1002/jcla.23464] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
13 Guvenir M, Arikan A. Hepatitis B Virus: From Diagnosis to Treatment. Pol J Microbiol 2020;69:391-9. [PMID: 33574867 DOI: 10.33073/pjm-2020-044] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
14 Ribeiro CRA, Martinelli KG, de Mello VDM, Baptista BDS, Dias NST, Paiva IA, Lewis-Ximenez LL, Pinto LMO, de Paula VS. Cytokine, Genotype, and Viral Load Profile in the Acute and Chronic Hepatitis B. Viral Immunol 2020;33:620-7. [PMID: 33090087 DOI: 10.1089/vim.2020.0176] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
15 Al‐saffar OB, Ad'hiah AH. Genetic variants in IL4RA , IL6 , and IL12B genes and susceptibility to hepatitis B and C virus infections among Iraqi patients. J Med Virol 2020;92:3448-58. [DOI: 10.1002/jmv.26297] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
16 Liu L, Zhang M, Hang L, Kong F, Yan H, Zhang Y, Feng X, Gao Y, Wang C, Ma H, Liu X, Zhan M, Pan Y, Xu H, Niu J. Evaluation of a new point-of-care oral anti-HCV test for screening of hepatitis C virus infection. Virol J 2020;17:14. [PMID: 32005264 DOI: 10.1186/s12985-020-1293-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
17 Cruz HM, de Paula VS, Cruz JCM, do Ó KMR, Milagres FAP, Bastos FI, Mota JCD, Cruz MS, Andrade TM, Pollo-Flores P, Leal E, Motta-Castro ARC, Ivantes CAP, Bezerra CS, Barbosa JR, da Cruz JNM, Lewis-Ximenez LL, Villar LM. Evaluation of accuracy of hepatitis B virus antigen and antibody detection and relationship between epidemiological factors using dried blood spot. J Virol Methods 2020;277:113798. [PMID: 31837375 DOI: 10.1016/j.jviromet.2019.113798] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
18 Arribas J, Benito R, Cebollada R, Bellés A, Bueno J, Cumbraos MJ, Gil J. Implications of grey zone results for routine hepatitis C virus screening with the ARCHITECT HCV-Ag assay. J Appl Microbiol 2020;128:899-906. [PMID: 31713922 DOI: 10.1111/jam.14517] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
19 Villar LM, Cruz HM, Deodato RM, Miguel JC, da Silva EF, Flores GL, Lewis-Ximenez LL. Usefulness of automated assays for detecting hepatitis B and C markers in dried blood spot samples. BMC Res Notes. 2019;12:523. [PMID: 31429797 DOI: 10.1186/s13104-019-4547-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
20 Pauly MD, Kamili S, Hayden TM. Impact of nucleic acid extraction platforms on hepatitis virus genome detection. J Virol Methods 2019;273:113715. [PMID: 31419455 DOI: 10.1016/j.jviromet.2019.113715] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
21 Kishanifarahani Z, Ahadi M, Kazeminejad B, Mollasharifi T, Saber Afsharian M, Sadeghi A, Bidari F, Jamali E, Hasanzadeh N, Movafagh A, Dehghan A, Moradi A, Moradi A. Inter-observer Variability in Histomorphological Evaluation of Non-neoplastic Liver Biopsy Tissue and Impact of Clinical Information on Final Diagnosis in Shahid Beheshti University of Medical Sciences Affiliated Hospitals. Iran J Pathol 2019;14:243-7. [PMID: 31583002 DOI: 10.30699/ijp.2019.99566.1985] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
22 Cruz HM, de Paula VS, da Silva EF, do Ó KMR, Milagres FAP, Cruz MS, Bastos FI, da Mota JC, Pollo-Flores P, Leal E, Motta-Castro ARC, Lewis-Ximenez LL, Lampe E, Villar LM. Utility of oral fluid samples for hepatitis B antibody detection in real life conditions. BMC Infect Dis 2019;19:632. [PMID: 31315573 DOI: 10.1186/s12879-019-4183-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
23 Villar LM, Bezerra CS, Cruz HM, Portilho MM, Flores GL. Applicability of Oral Fluid and Dried Blood Spot for Hepatitis B Virus Diagnosis. Can J Gastroenterol Hepatol 2019;2019:5672795. [PMID: 31058110 DOI: 10.1155/2019/5672795] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
24 Silva VCM, Calux SJ, Lemos MF, Compri AP, Santos APT, Oba IT, Mendes-Correa MCJ, Moreira RC. Fluctuations in serological hepatitis C virus levels in HIV patients. Rev Soc Bras Med Trop 2018;51:737-41. [PMID: 30517526 DOI: 10.1590/0037-8682-0239-2018] [Reference Citation Analysis]
25 Ibrahim IN, Mamman AI, Balogun MS, Babadoko AA, Hassan A, Augustine B, Suleiman AM, Kusfa IU. Towards 2030 Target for Hepatitis B and C Viruses Elimination: Assessing the Validity of Predonation Rapid Diagnostic Tests versus Enzyme-linked Immunosorbent Assay in State Hospitals in Kaduna, Nigeria. Niger Med J 2019;60:161-4. [PMID: 31543570 DOI: 10.4103/nmj.NMJ_93_18] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
26 Prasetyo AA, Marwoto M, Monica W. Interleukin-6-174 promoter polymorphism and susceptibility to hepatitis B virus infection in Javanese individuals. IOP Conf Ser : Mater Sci Eng 2018;434:012114. [DOI: 10.1088/1757-899x/434/1/012114] [Reference Citation Analysis]
27 Cruz HM, Barbosa JR, Baima Colares JK, de Moraes Neto AHA, Alencar MFL, Bastos FI, da Mota JC, Carvalho-Costa FA, Ivantes CAP, Lewis-Ximenez LL, Villar LM. Cross-sectional study to determine viral hepatitis knowledge in different urban populations in Brazil. World J Hepatol 2018;10:867-76. [PMID: 30533187 DOI: 10.4254/wjh.v10.i11.867] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
28 Hadziyannis E, Laras A. Viral Biomarkers in Chronic HBeAg Negative HBV Infection. Genes (Basel) 2018;9:E469. [PMID: 30262738 DOI: 10.3390/genes9100469] [Cited by in Crossref: 34] [Cited by in F6Publishing: 39] [Article Influence: 6.8] [Reference Citation Analysis]
29 Eaton KP, Chida N, Apfel A, Feldman L, Greenbaum A, Tuddenham S, Kendall EA, Pahwa A. Impact of nonintrusive clinical decision support systems on laboratory test utilization in a large academic centre. J Eval Clin Pract 2018;24:474-9. [PMID: 29446193 DOI: 10.1111/jep.12890] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
30 Cruz HM, Miguel Cruz JC, Da Silva EF, Portilho MM, Marques VA, Lewis-Ximenez LL, Lampe E, Villar LM. Comparison of the performance of enzyme immunoassays for hepatitis B and C detection in dried blood spot. J Immunoassay Immunochem 2018;39:228-33. [PMID: 29733758 DOI: 10.1080/15321819.2018.1470095] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
31 Bal T, Onlen Y. The prevalence of occult hepatitis B in chronic hepatitis C patients treated with interferon-based antiviral therapy. Arab J Gastroenterol 2018;19:33-6. [PMID: 29503077 DOI: 10.1016/j.ajg.2018.02.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
32 Cruz HM, de Paula VS, Villar LM. A Cross-Sectional Study of Viral Hepatitis Perception among Residents from Southeast and North Regions of Brazil. Int J Environ Res Public Health. 2018;15:E189. [PMID: 29364166 DOI: 10.3390/ijerph15020189] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
33 Köse Ş, Dal T. Laboratory Diagnosis of HBV. Viral Hepatitis: Chronic Hepatitis B 2018. [DOI: 10.1007/978-3-319-93449-5_5] [Reference Citation Analysis]
34 El-Sokkary RH, Tash RME, Meawed TE, El Seifi OS, Mortada EM. Detection of hepatitis C virus (HCV) among health care providers in an Egyptian university hospital: different diagnostic modalities. Infect Drug Resist 2017;10:357-64. [PMID: 29270026 DOI: 10.2147/IDR.S145844] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
35 Pondé RAA. The serological markers of acute infection with hepatitis A, B, C, D, E and G viruses revisited. Arch Virol 2017;162:3587-602. [PMID: 28884240 DOI: 10.1007/s00705-017-3538-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
36 Portilho MM, Mendonça A, Marques VA, Nabuco LC, Villela-Nogueira CA, Ivantes C, Lewis-Ximenez LL, Lampe E, Villar LM. Comparison of oral fluid collection methods for the molecular detection of hepatitis B virus. Oral Dis 2017;23:1072-9. [PMID: 28544047 DOI: 10.1111/odi.12692] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
37 Barbosa JR, Colares JKB, Flores GL, Cortes VF, Miguel JC, Portilho MM, Marques VA, Potsch DV, Brandão-Mello CE, Amendola-Pires M, Pilotto JH, Lima DM, Lampe E, Villar LM. Performance of rapid diagnostic tests for detection of Hepatitis B and C markers in HIV infected patients. J Virol Methods 2017;248:244-9. [PMID: 28782578 DOI: 10.1016/j.jviromet.2017.08.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
38 Adeyemi OO, Herod MR, Oladiji F, Fakunle YM, Babatunde AS, Agbede OO. A multi-template multiplex PCR assay for hepatitis B virus and human β-globin. J Med Virol 2017;89:1944-51. [PMID: 28618003 DOI: 10.1002/jmv.24877] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
39 Han S, Na GH, Kim DG. A 6-month mixed-effect pharmacokinetic model for post-transplant intravenous anti-hepatitis B immunoglobulin prophylaxis. Drug Des Devel Ther 2017;11:2099-107. [PMID: 28744101 DOI: 10.2147/DDDT.S134711] [Reference Citation Analysis]
40 Flores GL, Cruz HM, Potsch DV, May SB, Brandão-Mello CE, Pires MMA, Pilotto JH, Lewis-Ximenez LL, Lampe E, Villar LM. Evaluation of HBsAg and anti-HBc assays in saliva and dried blood spot samples according HIV status. J Virol Methods 2017;247:32-7. [PMID: 28506632 DOI: 10.1016/j.jviromet.2017.05.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
41 Flores GL, Cruz HM, Marques VA, Villela-Nogueira CA, Potsch DV, May SB, Brandão-Mello CE, Pires MMA, Pilotto JH, Pollo-Flores P, Esberard EBC, Ivantes C, Lewis-Ximenez LL, Lampe E, Villar LM. Performance of ANTI-HCV testing in dried blood spots and saliva according to HIV status. J Med Virol 2017;89:1435-41. [PMID: 28165155 DOI: 10.1002/jmv.24777] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
42 Das S, Shibib DR, Vernon MO. The new frontier of diagnostics: Molecular assays and their role in infection prevention and control. Am J Infect Control 2017;45:158-69. [PMID: 28159066 DOI: 10.1016/j.ajic.2016.08.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
43 Cruz HM, Scalioni LP, Paula VS, Miguel JC, Ó KM, Milagres FA, Cruz MS, Bastos FI, Flores PP, Leal E, Motta-Castro AR, Lewis-Ximenez LL, Lampe E, Villar LM. Poor sensitivity of rapid tests for the detection of antibodies to the hepatitis B virus: implications for field studies. Mem Inst Oswaldo Cruz 2017;112:209-13. [PMID: 28146158 DOI: 10.1590/0074-02760160394] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
44 Carlin J, Mendes-correa MC, Núñez M. Hepatitis B and C. Sexually Transmitted Infections in HIV-Infected Adults and Special Populations 2017. [DOI: 10.1007/978-3-319-56694-8_10] [Reference Citation Analysis]
45 Trucchi C, Orsi A, Alicino C, Sticchi L, Icardi G, Ansaldi F. State of the Art, Unresolved Issues, and Future Research Directions in the Fight against Hepatitis C Virus: Perspectives for Screening, Diagnostics of Resistances, and Immunization. J Immunol Res 2016;2016:1412840. [PMID: 27843956 DOI: 10.1155/2016/1412840] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
46 Wang L, Lv H, Zhang G. Hepatitis C virus core antigen assay: an alternative method for hepatitis C diagnosis. Ann Clin Biochem 2017;54:279-85. [PMID: 27614354 DOI: 10.1177/0004563216661218] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
47 Fan H, Lv P, Lv J, Zhao X, Liu M, Zhang G, Tang H. miR-370 suppresses HBV gene expression and replication by targeting nuclear factor IA. J Med Virol. 2017;89:834-844. [PMID: 27664977 DOI: 10.1002/jmv.24695] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
48 Cadieux G, Campbell J, Dendukuri N. Systematic review of the accuracy of antibody tests used to screen asymptomatic adults for hepatitis C infection. CMAJ Open 2016;4:E737-45. [PMID: 28018889 DOI: 10.9778/cmajo.20160084] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
49 Osiowy C, Coffin C, Andonov A. Review of Laboratory Tests used in Monitoring Hepatitis B Response to Pegylated Interferon and Nucleos(t)ide Analog Therapy. Curr Treat Options Infect Dis 2016;8:177-93. [PMID: 27547127 DOI: 10.1007/s40506-016-0080-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
50 El-Guindi MA. Hepatitis C Viral Infection in Children: Updated Review. Pediatr Gastroenterol Hepatol Nutr 2016;19:83-95. [PMID: 27437184 DOI: 10.5223/pghn.2016.19.2.83] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]